- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Linagliptin 5mg
Total 12983 results
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Recruiting
-
Newish Technology (Beijing) Co., Ltd.Recruiting
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 1 DiabetesUnited States
-
Vanderbilt UniversityCompletedHypertension | Metabolic SyndromeUnited States
-
BiogenTerminated
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type II
-
EMSNot yet recruitingType 2 Diabetes Mellitus
-
Khoo Teck Puat HospitalCompletedType II Diabetes in Subjects BMI 27 to 32Singapore
-
Emory UniversityBoston Medical Center; Rush University; University of DenverCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, New Zealand, Spain, Japan, Finland, Germany, Greece, Romania, South Africa, Denmark, Colombia, Poland, United Kingdom, Mexico, Australia, Belgium, Ireland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Canada, Denmark, Netherlands, Sweden
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes MellitusUnited States, Canada
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany
-
Samjin Pharmaceutical Co., Ltd.CompletedStroke, AcuteKorea, Republic of
-
Yonsei UniversityUnknownChronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 DiabetesKorea, Republic of
-
Fayoum UniversityBoehringer IngelheimCompletedDiabetes | Microalbuminuria | Kidney Function Affection Upon Exposure to RadiocontrastEgypt
-
Matias VestedNot yet recruitingNeuromuscular BlockadeDenmark
-
University Hospital UlmRecruitingPostoperative Complications | Neuromuscular Blockade, ResidualGermany
-
AstraZenecaCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedType 2 Diabetes MellitusChina
-
Boryung Pharmaceutical Co., LtdCompletedSmoking CessationKorea, Republic of
-
Daewon Pharmaceutical Co., Ltd.Completed
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Czech Republic, Finland, Greece, India, Israel, Mexico, New Zealand, Russian Federation, Sweden
-
University of VermontCompletedImpaired Glucose Tolerance | Pre-diabetes | Impaired Fasting GlucoseUnited States
-
Profil Institut für Stoffwechselforschung GmbHMerck Sharp & Dohme LLCCompletedPharmacological ActionGermany
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
LG Life SciencesCompletedType 2 DM Patients With Moderate or Severe Renal ImpairmentKorea, Republic of
-
Ministry of Public Health, ArgentinaAix Marseille Université; Instituto de Biología y Medicina Experimental, IBYME...Unknown
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownDiabetic Peripheral Neuropathy
-
PfizerTerminated
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Argentina, Belgium, Canada, China, Germany, Korea, Republic of, Philippines, Russian Federation, Taiwan, Turkey, United Kingdom
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Croatia, India, Israel, Italy, Malaysia, Netherlands, Poland, Romania, Slovakia, Thailand, Ukraine
-
Merck Sharp & Dohme LLCCompleted
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2United States, Puerto Rico, Germany, United Kingdom, Austria
-
Hansoh BioMedical R&D CompanyRecruiting
-
Shanghai Henlius BiotechActive, not recruiting
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital, Akershus and other collaboratorsRecruitingGlucose Metabolism Disorders | Impaired Glucose Tolerance | Insulin SensitivityNorway
-
University of Colorado, DenverMerck Sharp & Dohme LLCCompletedCardiovascular Disease | Type 2 DiabetesUnited States
-
University at BuffaloMerck Sharp & Dohme LLCCompletedType 2 DiabetesUnited States
-
Dong Wha Pharmaceutical Co. Ltd.CompletedHealthy SubjectsKorea, Republic of
-
National University of MalaysiaCompletedPreDiabetes | Type 2 DiabetesMalaysia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Israel, Malaysia, Mexico, Philippines, Puerto Rico, Russian Federation, Sri Lanka, Thailand, Ukraine
-
Universidad de GuanajuatoHospital Regional de Alta Especialidad del BajioCompletedInsulin Resistance | Prediabetic StateMexico
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States
-
Beni-Suef UniversityNot yet recruiting